Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAW039 in moderate to severe atopic dermatitis
NCT01785602Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of fevipiprant in atopic dermatitis (AD), sponsored by Novartis. Started Jun 2013; status: completed.
02
Drugs
fevipiprant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01785602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01785602.